For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and the formulated version represents a genuine change. These innovative therapies stabilize the transthyretin protein, slowing its damaging build-up and reducing the b